Pennsylvania HB2060 ensures non-opioid pain management drugs receive equal coverage in Medicaid and commercial insurance.

HB2060 amends the Human Services Code to mandate that non-opioid drugs for pain management receive equal coverage in Medicaid and commercial insurance. It prohibits more restrictive coverage criteria, utilization controls, or cost-sharing responsibilities for non-opioid drugs compared to opioids. This applies to drugs approved by the FDA for pain management and takes effect 60 days after enactment.

Pennsylvania HB2060 ensures non-opioid pain management drugs receive equal coverage in Medicaid and commercial insurance.

HB2060 amends the Human Services Code to mandate that non-opioid drugs for pain management receive equal coverage in Medicaid and commercial insurance. It prohibits more restrictive coverage criteria, utilization controls, or cost-sharing responsibilities for non-opioid drugs compared to opioids. This applies to drugs approved by the FDA for pain management and takes effect 60 days after enactment.